Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Albumin for hematoma size reduction in hemorrhagic stroke
IRCT201201018574N1Phase 2Completed
- Sponsor
- Ahvaz Jundishapur University of Medical Sciences
- Start
- Sep 2011
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of albumin (human) in brain hemorrhage (ICH), sponsored by Ahvaz Jundishapur University of Medical Sciences. Primary endpoint: Change in hematoma size. Started Sep 2011; status: completed.
02
Drugs
albumin (human)
03
Conditions
brain hemorrhage (ICH)
Beyond the preview
Go deeper on IRCT201201018574N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT201201018574N1.